Ovsianikov Alexandr

Head of the Group 3D Printing and Biofabrication at the TU Vienna 
Institute of Materials Science and Technology TU Vienna 

Prof. Aleksandr Ovsianikov is a head of the research group 3D Printing and Biofabrication at the TU Wien (Vienna, Austria). He is a member of the Austrian Cluster for Tissue Regeneration (http://www.tissue-regeneration.at) and was recently elected to the board of directors of the international society of biofabrication (https://biofabricationsociety.org). His research is dealing with the use of additive manufacturing technologies and bioprinting for tissue engineering and regeneration. Prof. Ovsianikov has background in laser physics and material processing with femtosecond lasers. A particular focus his current research is the development of multiphoton lithography technologies for engineering of biomimetic 3D cell culture matrices and realization of novel tissue engineering scaffolds. He was awarded a prestigious Starting Grant in 2012 and a Consolidator Grant in 2017 from the European Research Council (ERC) for projects aimed at these topics (http://amt.tuwien.ac.at/Ovsianikov).
Since 2004 Dr. Ovsianikov delivered multiple invited and keynote lectures, and has contributed to over 90 publications. Together with Prof. Mironov and Prof. Yoo he is an editor of a living book project “3D Printing and Biofabrication” published by Springer in cooperation with Tissue Engineering and Regenerative Medicine International Society (TERMIS).
He is also a co-founder and a head of research of a TU Wien spin-off UpNano GmbH (https://www.upnano.at). 

Title of Talk 
Laser-Based High Resolution 3D Printing for Biomedical Applications 

Additive manufacturing technologies, often referred to as 3D printing, open exciting perspectives for biomedical applications and tissue engineering. They range from producing patient-specific 3D scaffolds, which are subsequently seeded with cells, to direct processing of cell-containing materials in accordance to a computer assisted design (CAD) models, the so-called bioprinting. Among the myriad of possible approaches multiphoton lithography (MPL) stands out as a technique enabling true 3D structuring with spatial resolution down to submicrometer level. The portfolio of biocompatible MPL materials expanded substantially in the recent years. In this contribution the recent progress of MPL development for biomedical applications, will be discussed. The presentation is supported by numerous examples.